PSYCHOTROPIC MEDICATION USE IN ADOLESCENT PATIENTS WITH ACUTE AND TRANSIENT PSYCHOTIC DISORDER
Main Article Content
Abstract
Background: Psychotic disorders is one of the common mental diagnoses in clinical practice in adolescents. Treatment with antipsychotic is prescribed.
Objectives: Describe on psychotropic treatment for adolescents with psychosis disorder.
Particpants and Methods: 38 recruited in-patients diagnosed psychotic disorder according to ICD-10 criteria (F23) at National Institute of Mental Health during the period from 07/2021 to 06/2022. Retrospective descriptive study.
Results: At admission, the most commonly used antipsychotic was haloperidol, with 81.6% at a dose of 8.4±3.5 mg/day. At the time of hospital discharge, the most commonly used antipsychotic was risperidone, with 76.3% at an average dose of 3.7 ±1.4 mg/day. The medication most frequently combined during treatment was benzodiazepine, accounting for 81.6% with an average dose of 15 ± 5.3 mg/day; mood stabilizers were less frequently combined, at 26.3% of patients, with an average dose of Depakin 900 ± 516.4 mg/day. Upon discharge, mainly two types of antipsychotics were used, accounting for 68.4%, and one type for 23.7%. No patient used four or more types.
Conclusion: Priority for psychotic treatment is antipsychotic.
Keywords
psychotic disorder, antipsychotic, adolescents